Ra Medical Systems, Inc. , a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases.
Catheter Precision stock last closed at $0.88, down 7.68% from the previous day, and has decreased 84.61% in one year. It has underperformed other stocks in the Medical Devices industry by 0.24 percentage points. Catheter Precision stock is currently +3.18% from its 52-week low of $0.85, and -94.41% from its 52-week high of $15.68.
At the moment, there are 2.69M shares of VTAK outstanding. The market value of VTAK is $2.36M. In the past 24 hours, 92,000 VTAK shares were traded.
You need an online brokerage account in order to access the NYSEMKT market and buy VTAK shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you'll need to fill out some personal info so you are able to buy VTAK stock today.
Now that you have finished signing up on a mobile trading app, you can securely and quickly fund your account:
Watch the tutorial below for more details transferring funds into your investment account.
After you have identified the best place to buy Catheter Precision stock, it's important to research their stock prior to investing, so you can comprehend the risk as well as the upside.
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on VTAK's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge VTAK's fair value.
Using relative valuations methods:
You can access more valuation analysis on VTAK's stock here.
You can dig deeper into what analysts are projecting on the Catheter Precision stock forecast page.
Last year, VTAK revenue was $819.00k. During the past five year, VTAK's revenue has increased by 25.89% per year. This was faster than the Medical Devices industry average of 11.41%.
You can research VTAK's earnings and revenue performance here.
Over the last 12 months, insiders at VTAK have not bought or sold any shares.
Learn more about who owns VTAK shares here.
No, Catheter Precision doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary types of orders:
Hit the Open button and eToro will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some shares in VTAK, you'll want to keep up with your investment.
Create a watchlist to keep track of your VTAK stock.
To reiterate, here are the 6 steps to buy Catheter Precision stock:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Catheter Precision, click the button below.